Computational Method for Cancer Drug Development

The Physicians Committee
DONATE
 
BREAKING RESEARCH NEWS February 5, 2018

Computational Method for Cancer Drug Development

February 5, 2018

computational cancer

Image Source 

Study in a Sentence: Researchers used a mathematical method to convert genome-wide data on gene expression and epigenetic modifications (i.e., DNA modifications that regulate gene expression) from a human cancer stem cell line to a readily analyzable format and applied it to identify critical genes relating to cancer development and drug resistance. 

Healthy for Humans: The new computational approach can be used to assess the effectiveness of drugs for human cancers and identify new targets for cancer therapeutic development. 

Redefining Research: They were able to apply their method to identify a novel therapeutic target (TRAF4) for human gastrointestinal cancers that was previously studied in a mouse model. Thus, their method may serve to replace animals in cancer drug testing and development. 

Konno M, Matsui H, Koseki J, et al. Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells. Sci Rep. 2018;8:899. doi: 10.1038/s41598-018-19284-3

Subscribe to the Physicians Committee’s Breaking Research News.

Breaking Research News is a service of the Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave., Ste. 400, Washington, DC 20016, 202-686-2210. Join the Physicians Committee and receive the quarterly magazine, Good Medicine.

Breaking Research News Topics:
Breaking Research News Archive:
2018 (20)
2017 (44)
2016 (53)
2015 (53)
2014 (18)